Regeneron Pharma (REGN) PT Raised to $540 at Argus
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $799.08 +0.62%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 15
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 15
Join SI Premium – FREE
Argus analyst Jasper Hellweg raised the price target on Regeneron Pharma (NASDAQ: REGN) to $540.00 (from $430.00) while maintaining a Buy rating.
You May Also Be Interested In
- Morgan Stanley Upgrades DNB ASA (DNB:NO) (DNHBY) to Equalweight
- Paycom Software (PAYC) PT Raised to $285 at UBS
- Horizon Robotics Inc (9660:HK) PT Lowered to HK$8 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
